US Stock MarketDetailed Quotes

AVBP ArriVent BioPharma

Watchlist
  • 19.695
  • +0.495+2.58%
Trading Jul 19 10:15 ET
659.66MMarket Cap-8831P/E (TTM)

ArriVent BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-10.35%-18.63M
-27.99%-55.84M
6.13%-14.91M
-55.57%-15.44M
-8.61M
-16.88M
-43.63M
-15.89M
-9.93M
Net income from continuing operations
-43.09%-17.42M
-87.86%-69.33M
-102.96%-21.19M
-22.37%-14.4M
---21.57M
---12.17M
---36.91M
---10.44M
---11.77M
Change In working capital
62.34%-1.84M
276.19%12.6M
207.25%5.96M
-172.76%-1.26M
--12.77M
---4.88M
---7.15M
---5.56M
--1.73M
-Change in prepaid assets
79.30%-508K
171.23%9.67M
176.22%4.04M
167.29%2.18M
--5.9M
---2.45M
---13.58M
---5.3M
---3.24M
-Change in payables and accrued expense
44.71%-1.34M
-54.23%2.94M
850.97%1.93M
-169.45%-3.45M
--6.87M
---2.42M
--6.41M
---257K
--4.97M
-Change in other current assets
66.67%-1K
-318.75%-35K
-3,600.00%-35K
150.00%10K
---7K
---3K
--16K
--1K
--4K
-Change in other current liabilities
--10K
--25K
----
----
----
--0
--0
----
----
Cash from discontinued investing activities
Operating cash flow
-10.35%-18.63M
-27.99%-55.84M
6.13%-14.91M
-55.57%-15.44M
---8.61M
---16.88M
---43.63M
---15.89M
---9.93M
Investing cash flow
Cash flow from continuing investing activities
0
25M
0
0
0
0
Net investment purchase and sale
----
--0
--25M
--0
----
----
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
----
--0
--25M
--0
----
----
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
312.80%185.63M
-74.75%42.86M
-100.96%-1.06M
-1.03M
-20K
44.97M
169.72M
109.72M
0
Net common stock issuance
--185.63M
--0
--0
--0
--0
--0
--2K
--0
--0
Net preferred stock issuance
--0
-73.53%44.92M
--0
--0
---24K
--44.94M
--169.71M
--109.71M
--0
Proceeds from stock option exercised by employees
-96.15%1K
2,260.00%354K
1,800.00%285K
--39K
--4K
--26K
--15K
--15K
--0
Net other financing activities
----
---2.41M
---1.34M
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
312.80%185.63M
-74.75%42.86M
-100.96%-1.06M
---1.03M
---20K
--44.97M
--169.72M
--109.72M
--0
Net cash flow
Beginning cash position
-7.95%150.39M
338.23%163.37M
103.28%141.36M
98.62%157.83M
--191.46M
--163.37M
--37.28M
--69.54M
--79.46M
Current changes in cash
494.57%167M
-110.30%-12.98M
-90.38%9.03M
-65.98%-16.48M
---33.63M
--28.09M
--126.09M
--93.83M
---9.93M
End cash Position
65.78%317.39M
-7.95%150.39M
-7.95%150.39M
103.28%141.36M
--157.83M
--191.46M
--163.37M
--163.37M
--69.54M
Free cash flow
-10.35%-18.63M
-27.99%-55.84M
6.13%-14.91M
-55.57%-15.44M
---8.61M
---16.88M
---43.63M
---15.89M
---9.93M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -10.35%-18.63M-27.99%-55.84M6.13%-14.91M-55.57%-15.44M-8.61M-16.88M-43.63M-15.89M-9.93M
Net income from continuing operations -43.09%-17.42M-87.86%-69.33M-102.96%-21.19M-22.37%-14.4M---21.57M---12.17M---36.91M---10.44M---11.77M
Change In working capital 62.34%-1.84M276.19%12.6M207.25%5.96M-172.76%-1.26M--12.77M---4.88M---7.15M---5.56M--1.73M
-Change in prepaid assets 79.30%-508K171.23%9.67M176.22%4.04M167.29%2.18M--5.9M---2.45M---13.58M---5.3M---3.24M
-Change in payables and accrued expense 44.71%-1.34M-54.23%2.94M850.97%1.93M-169.45%-3.45M--6.87M---2.42M--6.41M---257K--4.97M
-Change in other current assets 66.67%-1K-318.75%-35K-3,600.00%-35K150.00%10K---7K---3K--16K--1K--4K
-Change in other current liabilities --10K--25K--------------0--0--------
Cash from discontinued investing activities
Operating cash flow -10.35%-18.63M-27.99%-55.84M6.13%-14.91M-55.57%-15.44M---8.61M---16.88M---43.63M---15.89M---9.93M
Investing cash flow
Cash flow from continuing investing activities 025M0000
Net investment purchase and sale ------0--25M--0----------0--0--0
Cash from discontinued investing activities
Investing cash flow ------0--25M--0----------0--0--0
Financing cash flow
Cash flow from continuing financing activities 312.80%185.63M-74.75%42.86M-100.96%-1.06M-1.03M-20K44.97M169.72M109.72M0
Net common stock issuance --185.63M--0--0--0--0--0--2K--0--0
Net preferred stock issuance --0-73.53%44.92M--0--0---24K--44.94M--169.71M--109.71M--0
Proceeds from stock option exercised by employees -96.15%1K2,260.00%354K1,800.00%285K--39K--4K--26K--15K--15K--0
Net other financing activities -------2.41M---1.34M------------------------
Cash from discontinued financing activities
Financing cash flow 312.80%185.63M-74.75%42.86M-100.96%-1.06M---1.03M---20K--44.97M--169.72M--109.72M--0
Net cash flow
Beginning cash position -7.95%150.39M338.23%163.37M103.28%141.36M98.62%157.83M--191.46M--163.37M--37.28M--69.54M--79.46M
Current changes in cash 494.57%167M-110.30%-12.98M-90.38%9.03M-65.98%-16.48M---33.63M--28.09M--126.09M--93.83M---9.93M
End cash Position 65.78%317.39M-7.95%150.39M-7.95%150.39M103.28%141.36M--157.83M--191.46M--163.37M--163.37M--69.54M
Free cash flow -10.35%-18.63M-27.99%-55.84M6.13%-14.91M-55.57%-15.44M---8.61M---16.88M---43.63M---15.89M---9.93M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg